Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 68382-034

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 68382-034). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Venlafaxine Hydrochloride Extended-release Capsules, Usp (E5d724aa Bc22 4503 B0e0 87b3b1d4a77e 01)

A chart showing pharmacokinetic fold changes and 90% confidence interval recommendations for venlafaxine hydrochloride when administered with various interacting drugs. The chart lists interacting drugs including ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium, and presents changes in analyte parameters such as Cmax and AUC relative to reference values, along with clinical recommendations like dose adjustments and caution.*

FDA Label Image

Venlafaxine Hydrochloride Extended-release Capsules, Usp (E5d724aa Bc22 4503 B0e0 87b3b1d4a77e 02)

A PKFold Change and 90% Confidence Interval chart showing the effect of various interacting drugs on analytes such as Cmax and AUC, with recommendations for dose adjustments or restrictions. The x-axis represents change relative to the reference value, ranging from 0 to 3. The chart includes drugs like ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium, alongside corresponding clinical recommendations.*

FDA Label Image

Venlafaxine Hydrochloride Extended-release Capsules, Usp (E5d724aa Bc22 4503 B0e0 87b3b1d4a77e 03)

A scatter plot chart showing the fold change and 90% confidence intervals for venlafaxine and its ODV metabolite pharmacokinetics (Cmax and AUC) across various special populations, including hepatic impairment, renal impairment, CYP2D6 polymorphism, age over 60, and gender. The chart includes recommendations for dose adjustments corresponding to these population groups.*

FDA Label Image

Venlafaxine Hydrochloride Extended-release Capsules, Usp (E5d724aa Bc22 4503 B0e0 87b3b1d4a77e 04)

Chemical structure diagram of venlafaxine hydrochloride showing its molecular arrangement including phenyl ring, hydroxyl group, and dimethylaminoethyl side chain, labeled as venlafaxine hydrochloride.*

FDA Label Image

Venlafaxine Hydrochloride Extended-release Capsules, Usp (E5d724aa Bc22 4503 B0e0 87b3b1d4a77e 05)

Label for Venlafaxine Hydrochloride Extended-Release Capsules, USP, 37.5 mg strength, in capsule, extended-release form. The label notes a quantity of 1,000 capsules for prescription use only. It is manufactured by Cadila Healthcare Ltd. and distributed by Zydus Pharmaceuticals USA Inc. The label includes storage instructions, dispensing guidance, and cautions for keeping medication out of reach of children.*

FDA Label Image

Venlafaxine Hydrochloride Extended-release Capsules, Usp (E5d724aa Bc22 4503 B0e0 87b3b1d4a77e 06)

The packaging label for Venlafaxine Hydrochloride Extended-Release Capsules, USP, 75 mg by Zydus Pharmaceuticals USA Inc. The label shows this is a 1,000 capsule bottle for prescription use only. It includes storage instructions, dosage guidance placeholder, and contact information for medication guides and manufacturer details from Cadila Healthcare Ltd., India.*

FDA Label Image

Venlafaxine Hydrochloride Extended-release Capsules, Usp (E5d724aa Bc22 4503 B0e0 87b3b1d4a77e 07)

Label for Venlafaxine Hydrochloride Extended-Release Capsules, USP, 150 mg strength. The label includes the NDC 68382-036-10, indicates the product is by Zydus Pharmaceuticals USA Inc., and contains 1,000 capsules. It includes dosage form as extended-release capsules, prescription-only status, storage instructions, and safety warnings about keeping the drug out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.